Are circulating endothelial-derived and platelet-derived microparticles a pathogenic factor in the cisplatin-induced stroke?

PubWeight™: 2.17‹?› | Rank: Top 2%

🔗 View Article (PMID 17379819)

Published in Stroke on March 22, 2007

Authors

Daniel Periard1, Chantal M Boulanger, Stephan Eyer, Nicolas Amabile, Paul Pugin, Christiane Gerschheimer, Daniel Hayoz

Author Affiliations

1: Service of Angiology, University Hospital, Lausanne, Switzerland. Daniel.Periard@chuv.ch

Articles by these authors

Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J (2006) 17.53

The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord (2008) 5.33

Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. J Am Coll Cardiol (2008) 3.18

Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol (2012) 2.59

Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: a monitoring test of endothelial dysfunction for clinical practice? J Am Coll Cardiol (2003) 2.59

Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood (2009) 2.40

Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. Am J Med (2004) 2.22

Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol (2005) 2.20

The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol (2011) 2.11

Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice. Circ Res (2013) 2.05

Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension (2006) 1.99

Endothelial microparticles in diseases. Cell Tissue Res (2008) 1.96

Mental stress induces prolonged endothelial dysfunction via endothelin-A receptors. Circulation (2002) 1.94

Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction. Circulation (2004) 1.90

Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice. Hypertension (2004) 1.89

CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization. J Am Coll Cardiol (2008) 1.82

Microparticles, vascular function, and atherothrombosis. Circ Res (2011) 1.78

Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol (2007) 1.72

Abnormal plasma microparticles impair vasoconstrictor responses in patients with cirrhosis. Gastroenterology (2012) 1.69

Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res (2014) 1.68

Postischemic forearm skin reactive hyperemia is related to cardovascular risk factors in a healthy female population. J Hypertens (2002) 1.64

Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation. Eur J Cardiovasc Prev Rehabil (2011) 1.55

Protective effect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention. Heart (2007) 1.51

Confounding effects of heart rate on pulse wave velocity in paced patients with a low degree of atherosclerosis. J Hypertens (2004) 1.47

Endothelial cell-derived microparticles loaded with iron oxide nanoparticles: feasibility of MR imaging monitoring in mice. Radiology (2012) 1.46

Circulating microparticles may influence early carotid artery remodeling. J Hypertens (2010) 1.45

Single-blind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins. Dermatol Surg (2004) 1.45

PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASH. Atherosclerosis (2011) 1.44

Intraluminal pressure increases vascular neuronal nitric oxide synthase expression. J Hypertens (2003) 1.42

Effect of mild endurance exercise training and pravastatin on peripheral vasodilatation of forearm resistance vessels in patients with coronary artery disease. Eur J Cardiovasc Prev Rehabil (2005) 1.40

Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration. Circ Res (2010) 1.36

High prevalence of peripheral arterial disease in HIV-infected persons. Clin Infect Dis (2008) 1.34

Low-pressure environment and remodelling of the forearm vein in Brescia-Cimino haemodialysis access. Nephrol Dial Transplant (2002) 1.29

Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetes-induced impaired neovascularization in ischemic limb muscles. Circ Res (2008) 1.29

Oxygen-derived free radicals mediate endothelium-dependent contractions to acetylcholine in aortas from spontaneously hypertensive rats. Br J Pharmacol (2002) 1.28

Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study. Eur J Cardiovasc Prev Rehabil (2009) 1.22

Gab1, SHP2, and protein kinase A are crucial for the activation of the endothelial NO synthase by fluid shear stress. Circ Res (2005) 1.20

Improvement of endothelial function with dietary flavanols is associated with mobilization of circulating angiogenic cells in patients with coronary artery disease. J Am Coll Cardiol (2010) 1.18

Microparticles: key protagonists in cardiovascular disorders. Semin Thromb Hemost (2010) 1.17

Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis. Haematologica (2012) 1.16

In vivo shear stress determines circulating levels of endothelial microparticles in end-stage renal disease. Hypertension (2007) 1.12

Alcohol drinking and cardiovascular risk in a population with high mean alcohol consumption. Am J Cardiol (2008) 1.12

Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study. Nephrol Dial Transplant (2011) 1.11

Intravenous fish oil blunts the physiological response to endotoxin in healthy subjects. Intensive Care Med (2007) 1.10

Proteomics, metabolomics, and immunomics on microparticles derived from human atherosclerotic plaques. Circ Cardiovasc Genet (2009) 1.10

Left ventricular remodeling after myocardial infarction: characterization of a swine model on beta-blocker therapy. Comp Med (2009) 1.09

Circulating platelet derived microparticles are not increased in patients with cirrhosis. J Hepatol (2013) 1.08

Shear stress regulates endothelial microparticle release. Circ Res (2013) 1.05

Increased carotid intima-media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease. Acta Paediatr Suppl (2006) 1.04

Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1. Am J Pathol (2007) 1.03

Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine. Hypertension (2008) 1.02

Nitric oxide synthase expression and functional response to nitric oxide are both important modulators of circulating angiogenic cell response to angiogenic stimuli. Arterioscler Thromb Vasc Biol (2010) 1.01

Diabetic neuropathy is a more important determinant of baroreflex sensitivity than carotid elasticity in type 2 diabetes. Hypertension (2005) 1.01

Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition. Arterioscler Thromb Vasc Biol (2006) 1.00

Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation? J Cell Mol Med (2012) 0.99

In vivo measurement of flow-mediated vasodilation in living rats using high-resolution ultrasound. Am J Physiol Heart Circ Physiol (2007) 0.98

Microparticles from ischemic muscle promotes postnatal vasculogenesis. Circulation (2009) 0.98

Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors. Circ Res (2004) 0.97

INS-1 cells undergoing caspase-dependent apoptosis enhance the regenerative capacity of neighboring cells. Diabetes (2010) 0.97

Erythrocyte microparticles can induce kidney vaso-occlusions in a murine model of sickle cell disease. Blood (2012) 0.95

Vascular risk factors in the Swiss population. J Neurol (2005) 0.95

Cap G, a gelsolin family protein modulating protective effects of unidirectional shear stress. J Biol Chem (2003) 0.94

Invasive management without stents in selected acute coronary syndrome patients with a large thrombus burden: a prospective study of optical coherence tomography guided treatment decisions. EuroIntervention (2015) 0.94

Uterine artery structural and functional changes during pregnancy in tissue kallikrein-deficient mice. Arterioscler Thromb Vasc Biol (2003) 0.93

Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland. Eur J Cardiovasc Prev Rehabil (2008) 0.91

Characterization of human late outgrowth endothelial progenitor-derived cells under various flow conditions. J Vasc Res (2011) 0.90

Cellular microparticles in the pathogenesis of pulmonary hypertension. Eur Respir J (2012) 0.89

Shear stress and cyclic circumferential stretch, but not pressure, alter connexin43 expression in endothelial cells. Cell Commun Adhes (2006) 0.89

Flow cytometry: retrospective, fundamentals and recent instrumentation. Cytotechnology (2012) 0.89

Tissue factor activity is upregulated in human endothelial cells exposed to oscillatory shear stress. Thromb Haemost (2002) 0.88

Predictive accuracy of original and recalibrated Framingham risk score in the Swiss population. Int J Cardiol (2008) 0.88

Ambulatory blood pressure monitoring: a mean to stratify cardiovascular risk. Blood Press Monit (2007) 0.88

Increased connexin43 expression in human saphenous veins in culture is associated with intimal hyperplasia. J Vasc Surg (2005) 0.88

Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy. Blood (2006) 0.87

Clinical prediction of deep venous thrombosis using two risk assessment methods in combination with rapid quantitative D-dimer testing. Am J Med (2002) 0.86

Prolonged therapy with erythropoietin is safe and prevents deterioration of left ventricular systolic function in a porcine model of myocardial infarction. J Card Fail (2010) 0.86

The impact of carotid plaque screening on motivation for smoking cessation. Nicotine Tob Res (2008) 0.86

Swimming prevents vulnerable atherosclerotic plaque development in hypertensive 2-kidney, 1-clip mice by modulating angiotensin II type 1 receptor expression independently from hemodynamic changes. Hypertension (2009) 0.85

Mechanical forces stimulate endothelial microparticle generation via caspase-dependent apoptosis-independent mechanism. Pulm Circ (2013) 0.85

Prevalence of normal weight obesity in Switzerland: effect of various definitions. Eur J Nutr (2008) 0.85

Severe hyperlipidemia causes impaired renin-angiotensin system function in apolipoprotein E deficient mice. Atherosclerosis (2005) 0.84

Circulating microparticles and procoagulant activity in elderly patients. J Gerontol A Biol Sci Med Sci (2009) 0.84

Dying for attention: microparticles and angiogenesis. Cardiovasc Res (2005) 0.84

Development of a selective peptide macrocycle inhibitor of coagulation factor XII toward the generation of a safe antithrombotic therapy. J Med Chem (2013) 0.83

Role of tissue kallikrein in response to flow in mouse resistance arteries. J Hypertens (2004) 0.83

Increased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferation. Diabetes (2009) 0.83

Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance. Br J Clin Pharmacol (2014) 0.83

[The culture of "useful error" in health care establishments: impact of morbidity and mortality conferences (MMCs)]. Rev Med Suisse (2010) 0.82

Circulating microparticles carry a functional endothelial nitric oxide synthase that is decreased in patients with endothelial dysfunction. J Am Heart Assoc (2012) 0.82

Surrogate markers for atherosclerosis in overweight subjects with atherogenic dyslipidemia: the GEMS project. Angiology (2008) 0.82

Proteomic analysis of secretory proteins and vesicles in vascular research. Proteomics Clin Appl (2008) 0.82

Intravital microscopy reveals endothelial dysfunction in resistance arterioles in Angiotensin II-induced hypertension. Hypertens Res (2012) 0.82

Acute endotoxemia inhibits microvascular nitric oxide-dependent vasodilation in humans. Shock (2011) 0.82

Granulocyte colony stimulating factor in myocardial infarction with low ejection fraction. Cytokine (2010) 0.81

Aspirin use for the primary prevention of coronary heart disease: a population-based study in Switzerland. Prev Med (2007) 0.81

Design and establishment of a biobank in a multicenter prospective cohort study of elderly patients with venous thromboembolism (SWITCO65+). J Thromb Thrombolysis (2013) 0.80

High prevalence of unsuspected abdominal aortic aneurysms in patients hospitalised for surgical coronary revascularisation. Eur J Cardiothorac Surg (2004) 0.80

Predictors of in-hospital mortality in elderly patients with acute venous thrombo-embolism: the SWIss Venous ThromboEmbolism Registry (SWIVTER). Eur Heart J (2011) 0.80

Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases. Cancer Genet Cytogenet (2005) 0.80